The government has said vaccines approved by certain countries, or listed by WHO, may be cleared for emergency use in India. Which foreign vaccines could arrive, and how will their safety be assessed With an aim to fast-track approvals for foreign manufacturers to market their Covid-19 vaccines in India, the government on Tuesday announced that vaccines that have been granted emergency approvals by US, UK and Japanese regulators, and those listed by the World Health Organization (WHO), may be granted emergency use approvals in India. The move comes at a time when vaccine shortages are being reported from various parts of the country. The Centre said the decision will facilitate quicker access to foreign vaccines in India. India’s current vaccination programme involves two vaccines — Covishield (Serum Institute of India) and Covaxin (Bharat Biotech) — while the expert body of the national regulator has recommended emergency use approval for Russia’s Sputnik V.